Tilray Medical expands veteran access at Aldershot event
Tilray Medical, through its subsidiary Lyphe Clinic Ltd., is promoting the Lyphe for Veterans programme at Armed Forces Weekend in Aldershot on June 27–28, 2026. The programme covers consultation and prescription fees for eligible veterans in the UK and Channel Islands. This effort follows the April 2026 acquisition of Lyphe Group by Tilray Brands, creating a vertically integrated medical cannabis platform.

*this image is generated using AI for illustrative purposes only.
Tilray Medical, a division of Tilray Brands, Inc., is expanding access to medical cannabis for veterans through its Lyphe for Veterans programme during Armed Forces Weekend in Aldershot on June 27–28, 2026. Lyphe Clinic Ltd., which became part of Tilray Medical in April 2026 following Tilray Brands’ acquisition of Lyphe Group, will host a dedicated stand to engage directly with veterans, service members, and their families. The activation aims to educate the community on the patient journey and the financial support available through the programme, which is designed to remove barriers to regulated clinical assessment.
Lyphe for Veterans Programme Details
Launched in late 2025, the Lyphe for Veterans programme is open to veterans of any nationality aged 18 or over residing in the UK or Channel Islands who can provide proof of veteran status. The initiative covers various costs associated with medical cannabis treatment to facilitate access.
| Covered Costs | Description |
|---|---|
| Initial consultation fees | Cost for the first clinical assessment |
| Follow-up appointment fees | Cost for subsequent check-ups |
| Summary Care Record handling | Administrative fees for record management |
| Repeat prescription request and delivery fees | Fees for dispensing and delivery via Lyphe Dispensary |
Strategic Expansion and Integration
The participation in Armed Forces Weekend underscores Tilray Medical’s commitment to building a connected healthcare platform in the UK. By integrating Lyphe’s clinic model and digital patient-access capabilities with Tilray’s international distribution network, the company aims to provide consistent and reliable medical cannabis access. The event in Aldershot, home to a significant Armed Forces population, is expected to draw between 20,000 and 40,000 attendees.
Rajnish Ohri, President, International, Tilray Brands, stated that the programme reflects patient-first innovation and reinforces the company’s mission to support veterans with care and discretion. The acquisition of Lyphe Group has established a vertically integrated platform spanning clinical care, dispensing, and pharmaceutical distribution across the region.
Will the success of the Lyphe for Veterans programme prompt Tilray to introduce similar subsidized access initiatives for other patient demographics?
How will Tilray Medical measure the success of the Armed Forces Weekend activation, and what metrics will determine future expansion of the programme?
Could the vertical integration achieved through the Lyphe acquisition lead to Tilray pursuing similar acquisitions in other European markets?























